Alys Pharmaceuticals (private company)
See something wrong or missing? Let us know
Offices:Geneva
Industry:Health servicesManufacturingPharma
Business model:B2B
Alys Pharmaceuticals is the merger result of six of dermatology-focused companies by Medicxi, doing R&D anchored immuno-dermatology to redefine the treatment landscape, bringing transformative solutions to patients worldwide
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 100M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Alys Pharmaceuticals
Name | Criteria | |
---|---|---|
![]() |
Beckley Psytech
58%
|
|
![]() |
Cytoki Pharma
58%
|
|
![]() |
Abalos Therapeutics
58%
|
|
![]() |
Emergence Therapeutics
58%
|
|
![]() |
SafeHeal
58%
|
|
![]() |
Precirix
58%
|
|
![]() |
Kither Biotech
58%
|
|
![]() |
OMass Therapeutics
58%
|
|
![]() |
Minoryx
58%
|
|
![]() |
Qubit Pharmaceuticals
58%
|
|